Advertisement
Singapore markets close in 6 hours 27 minutes

  • Straits Times Index

    3,251.14
    -13.39 (-0.41%)
     

  • Nikkei

    38,333.99
    +131.62 (+0.34%)
     

  • Hang Seng

    18,425.11
    +111.25 (+0.61%)
     

  • FTSE 100

    8,354.05
    +40.38 (+0.49%)
     

  • Bitcoin USD

    61,553.68
    -1,176.69 (-1.88%)
     

  • CMC Crypto 200

    1,310.52
    +15.85 (+1.22%)
     

  • S&P 500

    5,187.67
    -0.03 (-0.00%)
     

  • Dow

    39,056.39
    +172.13 (+0.44%)
     

  • Nasdaq

    16,302.76
    -29.80 (-0.18%)
     

  • Gold

    2,316.60
    -5.70 (-0.25%)
     

  • Crude Oil

    79.30
    +0.31 (+0.39%)
     

  • 10-Yr Bond

    4.4920
    +0.0290 (+0.65%)
     

  • FTSE Bursa Malaysia

    1,605.23
    +0.48 (+0.03%)
     

  • Jakarta Composite Index

    7,088.79
    -34.82 (-0.49%)
     

  • PSE Index

    6,689.34
    +30.16 (+0.45%)
     

Company News for Apr 21, 2020

Zacks Equity Research

  • Shares of Cyclacel Pharmaceuticals, Inc. CYCC surged 34.8% after the company announced a collaboration agreement with the University of Edinburgh to study its CDK Inhibitors to diminish runaway inflammation in COVID-19.

  • Shares of NovaBay Pharmaceuticals, Inc. NBY soared 69.7% after the company signed an agreement to distribute coronavirus antibody rapid point-of-care test to U.S. healthcare professionals.

  • Shares of Exelixis, Inc. EXEL rose 21.3% after the company announced the results from its Phase 3 CheckMate-9ER Trial, which met the primary endpoint.

  • Shares of Co-Diagnostics, Inc. CODX gained 11.4% after the company said its COVID-19 test orders in the United States have continued to rise.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Exelixis, Inc. (EXEL) : Free Stock Analysis Report
 
Cyclacel Pharmaceuticals, Inc. (CYCC) : Free Stock Analysis Report
 
NovaBay Pharmaceuticals, Inc. (NBY) : Free Stock Analysis Report
 
Co-Diagnostics, Inc. (CODX) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.